Zvi Shmuel Ben - Jun 30, 2022 Form 3 Insider Report for Protalix BioTherapeutics, Inc. (PLX)

Role
Director
Signature
/s/ Eyal Rubin, POA
Stock symbol
PLX
Transactions as of
Jun 30, 2022
Transactions value $
$0
Form type
3
Date filed
7/5/2022, 04:30 PM
Next filing
Sep 9, 2022

No securities are beneficially owned.